Prevalence of Hepatitis B Surface Antigen and Associated Factors among Diabetic Patients Attending Bugando Medical Centre in Mwanza, Tanzania
Abstract
Background: Hepatitis B virus is a significant public health concern, especially among high-risk groups such as diabetic patients. Hepatitis B infection can lead to serious liver diseases such as hepatocellular carcinoma and cirrhosis. Precise data on the prevalence of Hepatitis B infections in these high-risk groups are crucial for executing targeted interventions aimed at reducing Hepatitis B virus transmission. Here, we report the prevalence and factors associated with Hepatitis B infections among diabetic patients in Mwanza, Tanzania. Methodology: A cross-sectional study involving 177 diabetic patients was conducted between May and July 2023 at Bugando Medical Centre. Socio-demographic and other relevant information were collected using a structured, pretested data collection tool. Approximately 3-5 mL of blood sample was collected from each participant, followed by HbsAg testing using the One Step HBsAg Rapid Test kit. Descriptive analysis was performed using STATA version 15 software. Results: The median [IQR] age of participants was 61 [29-85] years. The prevalence of HBsAg among diabetic patients was 4.5% (8/177); 95% CI [1.4 –7.5]. Sharing cutting equipment was significantly associated with HBsAg positivity (p = 0.022). Conclusion: The prevalence of HBsAg among diabetic patients indicates intermediate endemicity as per WHO classification, with sharing of cutting equipment significantly contributing to Hepatitis B virus infection in this group. There is a need to include general education regarding HBV transmission in the management of diabetic patients
Downloads
References
Venkatakrishnan B, Zlotnick A. The structural biology of hepatitis B virus: form and function. Annual review of virology. 2016;3:429-51.
Yim HJ, Lok ASF. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006;43(S1):S173-S81.
John A, Ibrahim ZG, Magaji SY, Ede JS, Bello SA. Hepatitis B and C: a twin silent killer. World J Pharm Res. 2018;3.
Lamontagne RJ, Bagga S, Bouchard MJ. Hepatitis B virus molecular biology and pathogenesis. Hepatoma research. 2016;2:163.
Coppola N, Onorato L, Minichini C, Di Caprio G, Starace M, Sagnelli C, et al. Clinical significance of hepatitis B surface antigen mutants. World journal of hepatology. 2015;7(27):2729.
Martyn E, Eisen S, Longley N, Harris P, Surey J, Norman J, et al. The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda. Elife. 2023;12:e81070.
Kilonzo SB, Gunda DW, Majinge DC, Jaka H, Manyiri PM, Kalokola F, et al. Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study. BMC Infectious Diseases. 2021;21:1-9.
Ndako JA, Nwankiti OO, Olorundare JO, Ojo SK, Okolie CE, Olatinsu O, et al. Studies on the serological markers for hepatitis B virus infection among type 2 diabetic patients. Journal of Clinical Laboratory Analysis. 2021;35(1):e23464.
Chen H-F, Li C-Y, Chen P, See T-T, Lee H-Y. Seroprevalence of hepatitis B and C in type 2 diabetic patients. Journal of the Chinese Medical Association. 2006;69(4):146-52.
Cai C, Zeng J, Wu H, Shi R, Wei M, Gao Y, et al. Association between hepatitis B virus infection and diabetes mellitus: a meta-analysis. Experimental and therapeutic medicine. 2015;10(2):693-8.
Sabeena S, Ravishankar N. Horizontal modes of transmission of hepatitis B virus (HBV): a systematic review and meta-analysis. Iranian journal of public health. 2022;51(10):2181.
Munyogwa MJ, William R, Kibusi SM, Gibore NS. Clinical characteristics and health care received among patients with type 2 diabetes attending secondary and tertiary healthcare facilities in Mwanza Region, Tanzania: a cross-sectional study. BMC Health Services Research. 2020;20:1-11.
Wu F-Y, Liao Y-W, Wu J-F, Chen H-L, Hsu H-Y, Chang M-H, et al. A simple and rapid test-card method to detect hepatitis B surface antigen and antibody: potential application in young children and infants. Pediatrics & Neonatology. 2016;57(3):219-24.
Ott J, Stevens G, Groeger J, Wiersma S. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212-9.
Kombi PK, Agasa SB, Mukonkole JPM, Bome LB, Bokele CA, Tshilumba CK. Seroprevalence of hepatitis B and C virus infections among diabetic patients in Kisangani (North-eastern Democratic Republic of Congo). Pan African Medical Journal. 2018;31(1).
Thompson P, Parr JB, Holzmayer V, Carrel M, Tshefu A, Mwandagalirwa K, et al. Seroepidemiology of Hepatitis B in the Democratic Republic of the Congo. The American journal of tropical medicine and hygiene. 2019;101(1):226.
Villar LM, Geloneze B, Vasques ACJ, Pires MLE, Miguel JC, da Silva EF, et al. Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals. PloS one. 2019;14(2):e0211193.
Bai S, Dang W, Hong W, Liao W, Smith RD. The prevalence of hepatitis B in Chinese general population from 2018 to 2022: a systematic review and meta-analysis. BMC Infectious Diseases. 2024;24(1):211.
Ajuwon BI, Yujuico I, Roper K, Richardson A, Sheel M, Lidbury BA. Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of data published between 2010 and 2019. BMC infectious diseases. 2021;21:1-15.
Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. International journal of medical sciences. 2005;2(1):50.
mondiale de la Santé O, Organization WH. Weekly Epidemiological Record, 2017, vol. 92, 50 [full issue]. Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire. 2017;92(50):761-80.
Copyright (c) 2024 Betrand Msemwa, Raymond Leonard Mushi, Samson Onesmo, Hawa Hassan Mzee, Mwita Marwa, Helmut Nyawale, Stephen E. Mshana, Mariam M. Mirambo
This work is licensed under a Creative Commons Attribution 4.0 International License.
